With talks of a new collective bargaining agreement underway, the NFL and NFL Players Association have agreed to form two new joint medical committees, partly to study marijuana as a potential pain-management tool for NFL players.
As reported by Mark Maske of the Washington Post, the agreement isn't solely centered on the study of marijuana, but rather "a variety of pain-management issues and strategies for players." And yet it marks a potentially long-awaited step toward a revised league-wide drug policy, not to mention a new CBA.
Despite its legalization for those 21 and older in 10 different states, marijuana remains on the NFL's banned substance list, with players regularly tested for the drug and suspended for positive tests. Through the two new committees, however, both the NFL and NFLPA will "review teams' policies and practices for the use of prescription medication" -- and other forms of pain relief -- as Maske reported.